MX2019013377A - Procedimiento de detección de enfermedades inducidas por c. perfringens en animales. - Google Patents

Procedimiento de detección de enfermedades inducidas por c. perfringens en animales.

Info

Publication number
MX2019013377A
MX2019013377A MX2019013377A MX2019013377A MX2019013377A MX 2019013377 A MX2019013377 A MX 2019013377A MX 2019013377 A MX2019013377 A MX 2019013377A MX 2019013377 A MX2019013377 A MX 2019013377A MX 2019013377 A MX2019013377 A MX 2019013377A
Authority
MX
Mexico
Prior art keywords
marker
perfringens
animals
sample material
specific
Prior art date
Application number
MX2019013377A
Other languages
English (en)
Inventor
Stefan Pelzer
Richard Ducatelle
Frank Thiemann
Monika Flügel
Immerseel Filip Van
Evy Goossens
Florian Böhl
Sarah Hark
Original Assignee
Evonik Operations Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Operations Gmbh filed Critical Evonik Operations Gmbh
Priority claimed from PCT/EP2018/062090 external-priority patent/WO2018206690A1/en
Publication of MX2019013377A publication Critical patent/MX2019013377A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un procedimiento de detección de enfermedades inducidas por C. perfringens en animales, comprendiendo el procedimiento: a) recoger el material de muestra de un animal específico o de un grupo específico de animales en momentos consecutivos; b) determinar la cantidad de un primer marcador y un segundo marcador contenidos en el material de muestra; y c) determinar la proporción del primer marcador con respecto al segundo marcador contenidos en el material de muestra; en el que el primer marcador comprende una secuencia de polinucleótidos que es específica para la subespecie de C. perfringens que induce la enfermedad diana; y el segundo marcador comprende un polinucleótido que es específico para la especie C. perfringens; y en el que un aumento en la proporción del primer marcador con respecto al segundo marcador en el material de muestra analizado a lo largo del tiempo es una indicación de la enfermedad diana.
MX2019013377A 2017-05-12 2018-05-09 Procedimiento de detección de enfermedades inducidas por c. perfringens en animales. MX2019013377A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP17170811 2017-05-12
US201762531000P 2017-07-11 2017-07-11
CN201710646838 2017-08-01
PCT/EP2018/062090 WO2018206690A1 (en) 2017-05-12 2018-05-09 Method for detecting c. perfringens induced diseases in animals

Publications (1)

Publication Number Publication Date
MX2019013377A true MX2019013377A (es) 2020-09-21

Family

ID=62116895

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019013377A MX2019013377A (es) 2017-05-12 2018-05-09 Procedimiento de detección de enfermedades inducidas por c. perfringens en animales.

Country Status (12)

Country Link
US (1) US11643696B2 (es)
EP (2) EP3636774B1 (es)
KR (1) KR20200006108A (es)
CN (1) CN110832089A (es)
BR (1) BR112019023772A2 (es)
CA (1) CA3063287A1 (es)
DK (2) DK3636774T3 (es)
ES (2) ES2944359T3 (es)
HU (2) HUE055897T2 (es)
MX (1) MX2019013377A (es)
PL (2) PL3622082T3 (es)
RU (2) RU2769503C2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020012669A (es) * 2018-05-29 2021-02-09 Evonik Operations Gmbh Procedimiento in vitro para monitorear la carga de patogenos en una poblacion animal.
MX2020013555A (es) * 2018-06-15 2021-02-26 Evonik Operations Gmbh Procedimiento de deteccion temprana de un brote de enteritis necrotica en una poblacion aviar.

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538851A (en) * 1993-12-22 1996-07-23 Institut Pasteur And Cneva Primers for the amplification of genes coding for the enterotoxin and the lecithinase of Clostridium perfringens and their application to the determination of the presence and numeration of these bacteriae
US6218529B1 (en) * 1995-07-31 2001-04-17 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
FR2788780B1 (fr) 1999-01-27 2001-03-30 Ap Cells Inc Procede de preparation de vesicules membranaires
GB9927320D0 (en) 1999-11-18 2000-01-12 Chiron Spa Exosome separation
US6812023B1 (en) 2000-04-27 2004-11-02 Anosys, Inc. Methods of producing membrane vesicles
US20040101860A1 (en) 2002-11-27 2004-05-27 Jones Alison M. Predicting animal performance
WO2005019258A2 (en) 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US7374927B2 (en) * 2004-05-03 2008-05-20 Affymetrix, Inc. Methods of analysis of degraded nucleic acid samples
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
US8058000B2 (en) 2005-06-02 2011-11-15 The United States Of America As Represented By The U.S. Environmental Protection Agency Species-specific primer sets and identification of species-specific DNA sequences using genome fragment enrichment
US20070042354A1 (en) * 2005-08-19 2007-02-22 Engelhard Eric K Detecting pathogens in companion animals
KR100920971B1 (ko) 2007-03-08 2009-10-09 삼성에버랜드 주식회사 식품 위해 미생물 검출용 프라이머 및 이를 이용한 식품위해 미생물 검출방법
RU2474587C2 (ru) 2007-06-08 2013-02-10 Острэйлиан Паултри Срс Пти Лтд КЛОСТРИДИАЛЬНЫЙ ТОКСИН NetB
US20160041153A1 (en) 2008-11-12 2016-02-11 Kirk Brown Biomarker compositions and markers
EP3181705A1 (en) 2008-11-12 2017-06-21 Caris Life Sciences Switzerland Holdings GmbH Methods and systems of using exosomes for determining phenotypes
IT1406051B1 (it) 2010-08-05 2014-02-06 D M G Italia S R L Uso di hmgb1 come marcatore biologico di infiammazione intestinale umana, metodo non invasivo per la sua rilevazione in campioni fecali e kit relativo.
EP2495025A1 (en) 2011-03-04 2012-09-05 Fresenius Medical Care Deutschland GmbH Filter for the removal of micro-vesicles from biological fluids, methods and devices using such a filter
US9957558B2 (en) * 2011-04-28 2018-05-01 Life Technologies Corporation Methods and compositions for multiplex PCR
RU2472162C1 (ru) 2011-05-04 2013-01-10 Государственное научное учреждение Всероссийский научно-исследовательский институт экспериментальной ветеринарии им. Я.Р. Коваленко Россельхозакадемии Способ серологической диагностики вирусных желудочно-кишечных инфекций крупного рогатого скота методом иммуноферментного анализа
CN102697812B (zh) 2012-05-28 2013-08-14 山东农业大学 鸡胆汁来源的胞外体提取方法及其在免疫学上的应用
US10488403B2 (en) 2012-07-19 2019-11-26 Atlantic Cancer Research Institute Method for the isolation of microvesicles
HUE052368T2 (hu) 2012-10-02 2021-04-28 Oil Dri Corp Of America Agyag termék és annak alkalmazásai
KR101922128B1 (ko) 2012-12-04 2019-02-13 삼성전자주식회사 미세유동장치 및 이를 채용한 생물학적 시료 내의 표적 물질 농축방법
EP2746406B1 (en) 2012-12-18 2017-08-23 Samsung Electronics Co., Ltd. Composition and kit for diagnosing breast cancer including miRNAs within vesicle, and method of diagnosing breast cancer using the same
CN105026911B (zh) 2013-01-03 2019-01-22 外来体诊断公司 用于分离微囊泡的方法
JP2015039320A (ja) 2013-08-21 2015-03-02 日鉄住金環境株式会社 複数細菌の同時検出及び／又は定量方法
WO2015103710A1 (en) * 2014-01-13 2015-07-16 The Royal Institution For The Advancement Of Learning/Mcgill University Methods, reagents and kits for the assessment of bacterial infection
US20170204474A1 (en) 2014-07-16 2017-07-20 General Mills, Inc. Bulk Allele Discrimination Assay
CN104531867B (zh) 2014-12-25 2017-03-29 湖北省农业科学院畜牧兽医研究所 产气荚膜梭菌肠毒素阳性菌双重荧光定量pcr快速检测试剂盒
EP3112474A1 (en) 2015-06-29 2017-01-04 Evonik Degussa GmbH Method of detecting avian necrotic enteritis
CN104807992A (zh) * 2015-04-25 2015-07-29 东北农业大学 一种检测产气荚膜梭菌NetB毒素抗体的阻断ELISA方法
WO2016201272A1 (en) 2015-06-12 2016-12-15 King Abdulaziz City For Science And Technology Method of diagnosing patients with conditions caused by mendelian mutations
CN107090518B (zh) 2017-04-05 2020-03-20 苏州协云基因科技有限公司 腹泻相关病原体多重rt-pcr联合基因芯片检测试剂盒
US20200239938A1 (en) 2017-10-02 2020-07-30 Evonik Operations Gmbh In-process method for guiding measures against the propagation of salmonella and/or against the propagation of campylobacter in an animal flock
RU2020129391A (ru) 2018-03-02 2022-03-09 Эвоник Оперейшенс ГмбХ Способ in vitro выявления недостаточности кишечного барьера у животных
MX2020012669A (es) 2018-05-29 2021-02-09 Evonik Operations Gmbh Procedimiento in vitro para monitorear la carga de patogenos en una poblacion animal.
MX2020013555A (es) 2018-06-15 2021-02-26 Evonik Operations Gmbh Procedimiento de deteccion temprana de un brote de enteritis necrotica en una poblacion aviar.

Also Published As

Publication number Publication date
RU2769503C2 (ru) 2022-04-01
EP3622082A1 (en) 2020-03-18
DK3636774T3 (da) 2021-11-15
KR20200006108A (ko) 2020-01-17
RU2019139169A3 (es) 2021-09-13
CN110832089A (zh) 2020-02-21
CA3063287A1 (en) 2018-11-15
PL3636774T3 (pl) 2022-01-03
DK3622082T3 (da) 2023-06-12
BR112019023772A2 (pt) 2020-06-09
US20210139955A1 (en) 2021-05-13
EP3636774A1 (en) 2020-04-15
RU2019139169A (ru) 2021-06-15
US11643696B2 (en) 2023-05-09
PL3622082T3 (pl) 2023-07-31
HUE062498T2 (hu) 2023-11-28
HUE055897T2 (hu) 2021-12-28
EP3622082B1 (en) 2023-03-29
ES2944359T3 (es) 2023-06-20
ES2893470T3 (es) 2022-02-09
US20220025439A9 (en) 2022-01-27
RU2021135658A (ru) 2021-12-16
EP3636774B1 (en) 2021-08-25

Similar Documents

Publication Publication Date Title
IL283845A (en) Methods for detecting diseases while using rna analysis
SG10201903822XA (en) Method for the enrichment of circulating tumor dna
BR112018007040A2 (pt) método e aparelho para detectar e classificar a atividade convulsiva
PH12015502849A1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
EA201792155A1 (ru) Композиции и способы детектирования биологического загрязнителя
MX2014004794A (es) Seleccion de protocolo preferido de manejo y procesamiento de muestras para identificacion de biomarcadores de enfermedad y valoracion de calidad de muestra.
MY187050A (en) Cancer cell-specific antibody, anticancer agent, and cancer testing method
TR201819546T4 (tr) Numune tür kökeni için tespit yöntemleri.
WO2017079653A3 (en) Methods of detecting inflammatory markers and treating inflammatory conditions in companion animals
MX2019013377A (es) Procedimiento de detección de enfermedades inducidas por c. perfringens en animales.
FR3066071B1 (fr) Dispositif pour la collecte et la restitution de molecules odorantes et methode de detection.
SG10201806729VA (en) Novel assay to detect human periostin
MX2018001373A (es) Uso de los marcadores moleculares il-3, il-33 e il-12p40 para caracterizar la severidad de infecciones respiratorias por virus respiratorio sincitial y metapneumovirus humano.
EA201391408A1 (ru) Способ прогнозирования стиля передвижения у лошадей
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
MX2020009045A (es) Procedimiento in vitro para detectar disfuncion de la barrera intestinal en animales mediante la determinacion de ovotransferrina.
SG10201903424RA (en) ANTI HUMAN Gas6 MONOCLONAL ANTIBODY
MX2020013555A (es) Procedimiento de deteccion temprana de un brote de enteritis necrotica en una poblacion aviar.
EA202090447A1 (ru) Способ отбора жвачных животных в отношении желаемого наследуемого признака
AR111789A1 (es) Método para detectar enfermedades inducidas por c. perfringens en animales
MX2019002269A (es) Anticuerpo monoclonal contra quinasa de cremallera de leucina embrionaria materna (melk) y utilizacion del mismo.
MY187887A (en) Strongyloides stercoralis protein and/or corresponding dna and rna sequences for application in diagnosis
MX2017010352A (es) Metodos para diagnosticar enfermedad valvular cronica.
EA201500560A1 (ru) РАДИОЛИГАНДНЫЙ СПОСОБ КОЛИЧЕСТВЕННОЙ ОЦЕНКИ РЕЦЕПТОРНОЙ АКТИВНОСТИ β-АДРЕНОРЕЦЕПТОРОВ НА ПОВЕРХНОСТИ Т-ЛИМФОЦИТОВ ЧЕЛОВЕКА
PL415440A1 (pl) Sposoby identyfikacji jagniąt syntetycznych linii BCP i SCP o przydatnym w hodowli składzie tkankowym tuszy